9 January 2026 Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets read more
7 January 2026 Poplar Therapeutics Launches With $50M Series A to Advance a New Class of Anti-IgE Therapy for Multiple Atopic Conditions read more
1 December 2025 Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study read more
29 September 2025 ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update read more
